Cargando…

Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study

Metabolic syndrome (MetS), defined as the coexistence of interrelated cardiometabolic risk factors, is limited by ignoring the severity of the disease and individuals with a pre-metabolic state. We aimed to develop the first age- and sex-specific continuous MetS severity score in the adult populatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honarvar, Mohammadjavad, Masoumi, Safdar, Mehran, Ladan, Khalili, Davood, Amouzegar, Atieh, Azizi, Fereidoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170075/ https://www.ncbi.nlm.nih.gov/pubmed/37160960 http://dx.doi.org/10.1038/s41598-023-33294-w

Ejemplares similares

Trajectory patterns of metabolic syndrome severity score and risk of type 2 diabetes
por: Amouzegar, Atieh, et al.
Publicado: (2023)

BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
por: Mehran, Ladan, et al.
Publicado: (2022)

Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
por: Honarvar, Mohammadjavad, et al.
Publicado: (2023)

Tehran Thyroid Study (TTS)
por: Amouzegar, Atieh, et al.
Publicado: (2018)

Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Parizadeh, Donna, et al.
Publicado: (2018)

Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
por: Abdi, Hengameh, et al.
Publicado: (2018)

Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study
por: Mahdavi, Mahdi, et al.
Publicado: (2021)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021)

The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
por: Amouzegar, Atieh, et al.
Publicado: (2017)

Smoking status and changes in thyroid-stimulating hormone and free thyroxine levels during a decade of follow-up: The Tehran thyroid study
por: Kadkhodazadeh, Hoda, et al.
Publicado: (2020)

Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism
por: Mehran, Ladan, et al.
Publicado: (2017)

Association between Physical Activity and Metabolic Risk Factors in Adolescents: Tehran Lipid and Glucose Study
por: Fam, Bita, et al.
Publicado: (2013)

Leisure-Time Physical Activity and Its Association With Metabolic Risk Factors in Iranian Adults: Tehran Lipid and Glucose Study, 2005–2008
por: Faam, Bita, et al.
Publicado: (2013)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
por: Azizi, Fereidoun, et al.
Publicado: (2020)

The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis
por: Amirabadizadeh, Alireza, et al.
Publicado: (2023)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial
por: Mehran, Ladan, et al.
Publicado: (2023)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease in a Population-based Study: Tehran Thyroid Study
por: Kazempour-Ardebili, Sara, et al.
Publicado: (2021)

Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study
por: Cheraghi, Leila, et al.
Publicado: (2021)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
por: Ahi, Salma, et al.
Publicado: (2019)

Tehran Lipid and Glucose Study: A National Legacy
por: Azizi, Fereidoun
Publicado: (2018)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Primordial and Primary Preventions of Thyroid Disease
por: Azizi, Fereidoun, et al.
Publicado: (2017)

Correction: Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study
por: Ahi, Salma, et al.
Publicado: (2019)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study
por: Amiri, Parisa, et al.
Publicado: (2023)

Health-related quality of life in men and women who experienced cardiovascular diseases: Tehran Lipid and Glucose Study
por: Jalali-Farahani, Sara, et al.
Publicado: (2021)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Contributions and Implications of the Tehran Lipid and Glucose Study
por: Azizi, Fereidoun, et al.
Publicado: (2018)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study
por: Naseri, Parisa, et al.
Publicado: (2020)

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qacfibhmjp0lj32njk5c9lsti7